Auxilium Pharmaceuticals
Centerbrook, Connecticut, United States
About Auxilium Pharmaceuticals
Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle, Auxilium’s mission has expanded to include the development and marketing of novel treatment options for many of society’s unmet medical needs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Total funding: $43.0M
- Funding stage: M&A
- Last round: Series D (Nov 2003)
- Ticker: nasdaq:AUXL
- Website: auxilium.com
- Phone: (484)321-5900
Industries & Categories
Biotechnology, Health Care, Market Research, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/auxilium-pharmaceuticals-2499916 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.